Building on the momentum achieved so far, the company's management expects SRF to finish the year on a reasonably strong ...
NATCO Pharma said that it has received approval of its ANDA for Everolimus tablets for oral suspension (TFOS), a generic version of AFINITOR DISPERZ by Novartis Pharmaceutical Corporation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback